Trial reportDiabetes technology & therapeutics2021
More Time in Glucose Range During Exercise Days than Sedentary Days in Adults Living with Type 1 Diabetes.
Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph
Trial report in Diabetes technology & therapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05478707 (Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes), which is not on this map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
PMID 29310645PMID 24742660PMID 22732108PMID 27295427PMID 27436611PMID 27633186PMID 29371269PMID 17711996PMID 19654321PMID 19672102PMID 20339920PMID 20739685other papers from this trial
Open the trial in the graphWho cites it
23 citing papers in PubMed.
- Trial
- Exercise in type 1 diabetes: real-world data on glucose levels and hypoglycaemia risk from over 420,000 exercise sessions.Diabetologia · 2026Observational
- Variation in Hypoglycemia Risk During Real-World Physical Activity in Adults with Type 1 Diabetes: Insights from the Type 1 Diabetes Exercise Initiative.Diabetes technology & therapeutics · 2026Article
- Association of Physical Activity and Socioeconomic Status With Glycaemic Control in Adults With Type 1 Diabetes: A Cross-Sectional Study Using CGM Data.Diabetes/metabolism research and reviews · 2026Article
- Cross-fusion of digital twins and artificial intelligence in diabetes: from mechanistic elucidation to full-cycle precision management.Frontiers in endocrinology · 2026Review
- A hierarchical network model for the estimate of the energy expenditure in individuals with type 1 diabetes.Engineering applications of artificial intelligence · 2025Article
- Physical Activity Is Associated With Improved Glycemic Outcomes in Newly Diagnosed Youth With Type 1 Diabetes: 4T Exercise Program.Diabetes care · 2025Article
- Proposed Practical Guidelines to Improve Glycaemic Management by Reducing Glycaemic Variability in People with Type 1 Diabetes Mellitus.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025Review
- Online Classification of Unstructured Free-Living Exercise Sessions in People with Type 1 Diabetes.Diabetes technology & therapeutics · 2024Article
- Design of a Real-Time Physical Activity Detection and Classification Framework for Individuals With Type 1 Diabetes.Journal of diabetes science and technology · 2024Article
- Analyzing Diabetes Detection and Classification: A Bibliometric Review (2000-2023).Sensors (Basel, Switzerland) · 2024Review
- Observational
- Design andJournal of diabetes science and technology · 2024Article
- Analysis of the management and therapeutic performance of diabetes mellitus employing special target.World journal of diabetes · 2023Review
- Review
- Hypoglycemia and glycemic variability of people with type 1 diabetes with lower and higher physical activity loads in free-living conditions using continuous subcutaneous insulin infusion with predictive low-glucose suspend system.BMJ open diabetes research & care · 2023Article
- 2022: Position of Brazilian Diabetes Society on exercise recommendations for people with type 1 and type 2 diabetes.Diabetology & metabolic syndrome · 2023Review
- Relationship Between Moderate-to-Vigorous Physical Activity and Glycemia Among Young Adults with Type 1 Diabetes and Overweight or Obesity: Results from the Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON) Study.Diabetes technology & therapeutics · 2022Article
- Advancements and future directions in the teamwork, targets, technology, and tight control-the 4T study: improving clinical outcomes in newly diagnosed pediatric type 1 diabetes.Current opinion in pediatrics · 2022Review
- Quantifying the impact of physical activity on future glucose trends using machine learning.iScience · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Michael C RiddellSchool of Kinesiology and Health Science, York University, Toronto, Canada.
Zoey LiJaeb Center for Health Research, Tampa, Florida, USA.
Roy W BeckJaeb Center for Health Research, Tampa, Florida, USA.
Robin L GalJaeb Center for Health Research, Tampa, Florida, USA.
Peter G JacobsOregon Health and Science University, Portland, Oregon, USA.
Jessica R CastleOregon Health and Science University, Portland, Oregon, USA.
Melanie B GillinghamOregon Health and Science University, Portland, Oregon, USA.
Mark ClementsChildren's Mercy Hospital, Kansas City, Missouri, USA.
Susana R PattonCenter for Healthcare Delivery Science, Nemours Children's Specialty Clinic, Jacksonville, Florida, USA.
Eyal DassauHarvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts, USA.
Francis J Doyle IiiHarvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts, USA.
Corby K MartinPennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana, USA.
Peter CalhounJaeb Center for Health Research, Tampa, Florida, USA.
Michael R RickelsPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Funding
Phenotypic Diversity in COVID-19UL1TR001878 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2016 to 2025
$102.4MClinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0MTracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1MVIRAL VECTOR COREP30DK019525 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI JOSHUA D RABINOWITZ · 1986 to 2026
$48.3MResearch BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI ROBERT A KESTERSON · 2005 to 2026
$26.5MNCATS NIH HHS UL1 TR001873NCATS NIH HHS UL1 TR001878NIDDK NIH HHS P30 DK019525NIDDK NIH HHS P30 DK072476NIGMS NIH HHS U54 GM104940
Abstract
PubMed holds no abstract for this paper.
Indexed as
Diabetes Mellitus, Type 1AdolescentAdultAgedBlood GlucoseBlood Glucose Self-MonitoringGlucoseGlycated HemoglobinHumansMiddle AgedYoung AdultBlood GlucoseGlucoseGlycated HemoglobinContinuous glucose monitoringExercisehyperglycemiahypoglycemiaphysical activityTime in rangeType 1 diabetes
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
NCT05478707ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.